1. Home
  2. RAYA vs LSTA Comparison

RAYA vs LSTA Comparison

Compare RAYA & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$4.20

Market Cap

4.2M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
LSTA
Founded
2019
1980
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
20.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
RAYA
LSTA
Price
$4.20
$2.07
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
32.8K
23.0K
Earning Date
04-17-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,101,325.00
$1,070,000.00
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.78
N/A
52 Week Low
$3.13
$1.81
52 Week High
$736.99
$4.20

Technical Indicators

Market Signals
Indicator
RAYA
LSTA
Relative Strength Index (RSI) 49.89 49.24
Support Level $3.95 $1.96
Resistance Level $4.50 $2.10
Average True Range (ATR) 0.46 0.11
MACD -0.02 0.02
Stochastic Oscillator 27.92 61.11

Price Performance

Historical Comparison
RAYA
LSTA

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: